An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject in Subjects with Type 2 Diabetes Mellitus [EXTENSION OF 700027845]
Latest Information Update: 17 Feb 2013
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Biodel
- 17 Feb 2013 New trial record